Transient dysaesthesiae and persistent leucocytosis after clioquinol therapy.
D000328:Adult; D000891:Anti-Infective Agents, Local / Q000009:adverse effects* / Q000627:therapeutic use; D001132:Arm; D001200:Ascaris / Q000302:isolation & purification; D001772:Blood Cell Count; D007464:Clioquinol / Q000009:adverse effects* / Q000627:therapeutic use; D003967:Diarrhea / Q000188:drug therapy / Q000209:etiology; D005145:Face; D005243:Feces / Q000382:microbiology; D005872:Giardia / Q000302:isolation & purification; D005873:Giardiasis / Q000150:complications; D006801:Humans; D007964:Leukocytosis / Q000139:chemically induced*; D008297:Male; D009325:Nausea / Q000139:chemically induced; D009461:Neurologic Manifestations; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced*; D012677:Sensation; D006113:United Kingdom; D014994:Xylose / Q000652:urine
D000891:Anti-Infective Agents, Local; D007464:Clioquinol; D014994:Xylose